596 related articles for article (PubMed ID: 3274453)
21. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
[No Abstract] [Full Text] [Related]
22. Elective cyclosporine conversion from triple therapy.
Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH
Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532
[No Abstract] [Full Text] [Related]
23. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
[No Abstract] [Full Text] [Related]
24. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
[No Abstract] [Full Text] [Related]
25. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
Schweizer RT; Rovelli M; Roper L; Bartus SA
Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
[No Abstract] [Full Text] [Related]
26. Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?
Melzer JS; Husing RM; Feduska NJ; Tomlanovich SJ; Vincenti F; Amend WJ; Garovoy M; Salvatierra O
Transplant Proc; 1987 Feb; 19(1 Pt 3):1971-3. PubMed ID: 2856274
[No Abstract] [Full Text] [Related]
27. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
[No Abstract] [Full Text] [Related]
28. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
[No Abstract] [Full Text] [Related]
29. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
Mieny CJ; Nel PJ; Becker JH; Pretorius JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
[No Abstract] [Full Text] [Related]
30. Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
Vanrenterghem Y; Waer M; Roels L; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1990 Aug; 22(4):1691-2. PubMed ID: 2389434
[No Abstract] [Full Text] [Related]
31. Immunohistology or conventional histology for the diagnosis of renal allograft rejection?
McWhinnie DL; Hughes D; Fuggle SV; Dunnill MS; Carter NP; Morris PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1888-9. PubMed ID: 2652613
[No Abstract] [Full Text] [Related]
32. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
[No Abstract] [Full Text] [Related]
33. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
34. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
35. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
36. A controlled trial of triple therapy in renal transplantation.
Salaman JR; Griffin PJ; Ross WB; Williams JD
Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
[No Abstract] [Full Text] [Related]
37. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
Mourad G; Legendre C; Argiles A; Bonardet A; Mion C
Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
[No Abstract] [Full Text] [Related]
38. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL
Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
[No Abstract] [Full Text] [Related]
39. [Triple immunosuppression in renal transplantation in children: 3 years' experience].
Trompeter RS
Pediatrie; 1989; 44(2):87-91. PubMed ID: 2654877
[TBL] [Abstract][Full Text] [Related]
40. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
